Survey Study About Endoscopy During COVID-19 Pandemic for IBD Doctors

Patterns of Endoscopy During COVID-19 Pandemic: a Global Survey of Interventional Inflammatory Bowel Disease Practice

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04970849

Enrollment

200

Registered

2021-07-21

Start date

2021-07-15

Completion date

2021-07-15

Last updated

2021-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory Bowel Diseases

Brief summary

Performance of diagnostic or therapeutic endoscopic procedures in inflammatory bowel disease (IBD) patients can be challenging during a viral pandemic; the main concerns being the safety and protection of patients and health care providers (HCP). The aim of this study is to identify endoscopic practice patterns and outcomes of IBD and coronavirus disease 19 (COVID-19) with a worldwide survey of HCP.

Detailed description

The 20-item survey questionnaire was sent to physician members of the American Society for Gastrointestinal Endoscopy Special Interest Group in Interventional IBD, Chinese IBD Society Endoscopy Interest Group, and the China Crohn's and Colitis Foundation. The data of the survey was collected and analyzed.

Interventions

OTHERobservation

IBD doctors who perform the endoscopy perform the questionnaire

Study design

Observational model

OTHER

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

1. Doctors who are involved in the endoscopic treatment of IBD patients; 2. The endoscopist reads and signs an informed consent online. -

Exclusion criteria

1. Doctors who are not involved in the endoscopic treatment of IBD patients 2. Doctors who need the help of an agent, a witness, or someone else who can not complete the questionnaire independently. 3. Other conditions that the researchers considered unsuitable for inclusion or influenced the participants'ability to complete the study.-

Design outcomes

Primary

Measure	Time frame	Description
The influence of covid-19 pandemic on endoscopic practice by IBD endoscopist	1 week	The incidence of scheduled IBD endoscopies were postponed or cancelled due to the pandemic.

Secondary

Measure	Time frame	Description
The incidence of COVID19 in IBD patients who underwent endoscopy	1 week	The percentage of IBD patients who underwent endoscopy since the outbreak was tested positive for COVID 19

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026